Current Treatment Options in Oncology
ISSN 1527-2729 · Springer Science+Business Media · United States · active 1982–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Current Treatment Options in Oncology a predatory journal?
Our screening does not flag Current Treatment Options in Oncology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Current Treatment Options in Oncology indexed in Scopus or Web of Science?
Per our venue index, Current Treatment Options in Oncology appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Current Treatment Options in Oncology's impact?
Papers in Current Treatment Options in Oncology are cited about 4.9 times each within two years of publication, and Scimago places it in Q1, with an h-index of 88. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Current Treatment Options in Oncology open access?
We hold no reliable open-access classification for Current Treatment Options in Oncology. Check the journal's own site for its access model and any article processing charge.